Camran Nezhat Q&A: Minimizing Harm and Improving Recovery
Our leading clinical experts discuss how MOSES 2.0 demonstrates more efficient lithotripsy and BPH procedures while allowing a same day, catheter free, discharge.
While the use of percutaneous access has long been accepted as a feasible modality for treating large urinary stones – it is still considered to be a challenging procedure due to associated morbidity. In recent years, with the advent of miniaturized nephroscopes, improved accessories and advanced laser technologies, PCNL can be done with smaller than ever tract sizes, unleashing the full advantages of this surgical technique.
Join our academic session and discover how MOSES 2.0 demonstrates improved efficiencies, with 50% less stone retropulsion and 40% faster hemostasis during BPH treatments – reducing overall surgical time and anesthesia use.
We are excited to share with you the MOSES Technology 360° educational experience – an in-depth platform featuring the MOSES innovations, product features, and key patient benefits.